Tarek Hassanein
Physician · Innovative Medical Solutions Inc A Medical Group
Credentials: · · · · ·
History
- 2026–Present
Innovative Medical Solutions Inc A Medical Group
- 1992–1994
- 1988–1990
- 1987–1988
Transplant Hepatology
- 1984–1987
- 1978–1982
ALEXANDRIA UNIV, ALEXANDRIA
Research
Sofosbuvir for previously untreated chronic hepatitis C infection
New England Journal of Medicine · 2013 · 1,382 citations
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection
New England Journal of Medicine · 2014 · 930 citations
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV
New England Journal of Medicine · 2014 · 582 citations
- DV
34 papers
14 papers
12 papers
- MS
12 papers
9 papers
9 papers
- KR
9 papers
- RH
9 papers
Grants
- 2003–2006
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $5.3K · University of California, San Diego
Clinical trials
- 2025–2026
Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis
Principal investigator · Not yet recruiting · Phase 1
Nterica Bio inc
- 2016–2017
Principal investigator · Completed · Phase 2
Trek Therapeutics, PBC
- 2016–2018
Principal investigator · Terminated · Phase 3
Vital Therapies, Inc.
- 2015–2016
Principal investigator · Completed · Phase 2
Trek Therapeutics, PBC